These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

217 related articles for article (PubMed ID: 10916046)

  • 21. Parkinson's disease.
    Clarke C; Moore AP
    Clin Evid; 2002 Jun; (7):1208-20. PubMed ID: 12230738
    [No Abstract]   [Full Text] [Related]  

  • 22. Parkinson's disease.
    Clarke C; Moore AP
    Clin Evid; 2003 Dec; (10):1582-98. PubMed ID: 15555162
    [No Abstract]   [Full Text] [Related]  

  • 23. Parkinson's disease.
    Clarke CE; Moore AP
    Am Fam Physician; 2007 Apr; 75(7):1045-8. PubMed ID: 17427619
    [No Abstract]   [Full Text] [Related]  

  • 24. Pharmacologic management of Parkinson's disease in long-term care residents: maintaining functionality to improve quality of life.
    Silver DE
    Director; 2007; 15(2):20-9. PubMed ID: 19343903
    [No Abstract]   [Full Text] [Related]  

  • 25. Levodopa in the treatment of Parkinson's disease: current controversies.
    Gerlach M; Reichmann H; Riederer P
    Mov Disord; 2005 May; 20(5):643; author reply 643-4. PubMed ID: 15732130
    [No Abstract]   [Full Text] [Related]  

  • 26. [Parkinson disease. Directed use of modern therapy].
    Möller JC; Wächter T; Oertel WH
    MMW Fortschr Med; 2001 May; 143 Suppl 2():45-50. PubMed ID: 11434257
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Parkinson's disease.
    Clarke C; Moore A
    Clin Evid; 2002 Dec; (8):1370-85. PubMed ID: 12603943
    [No Abstract]   [Full Text] [Related]  

  • 28. Parkinson's disease.
    Clarke C; Moore AP
    Clin Evid; 2004 Jun; (11):1736-54. PubMed ID: 15652077
    [No Abstract]   [Full Text] [Related]  

  • 29. Levodopa in the early treatment of Parkinson's disease.
    Murata M
    Parkinsonism Relat Disord; 2009 Jan; 15 Suppl 1():S17-20. PubMed ID: 19131036
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Future therapies for Parkinson's disease.
    Hauser RA; Lyons KE
    Neurol Clin; 2004 Oct; 22(3 Suppl):S149-66. PubMed ID: 15501363
    [No Abstract]   [Full Text] [Related]  

  • 31. Effects of L-DOPA on spatiotemporal contrast sensitivity in Parkinson's disease.
    Mestre DR; Blin O; van den Brand CL; Azulay JP; Serratrice G
    Adv Neurol; 1996; 69():503-11. PubMed ID: 8615172
    [No Abstract]   [Full Text] [Related]  

  • 32. Selegiline slows the progression of the symptoms of Parkinson disease.
    Pålhagen S; Heinonen E; Hägglund J; Kaugesaar T; Mäki-Ikola O; Palm R;
    Neurology; 2006 Apr; 66(8):1200-6. PubMed ID: 16540603
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Parkinson's disease].
    Jean-Luc H
    Rev Prat; 2005 May; 55(10):1129-34. PubMed ID: 16097259
    [No Abstract]   [Full Text] [Related]  

  • 34. [Pergolide: a useful agonist for the treatment of Parkinson disease].
    Bonnet AM; Houeto JL
    Rev Neurol (Paris); 2002 Jul; 158(6-7):744-5. PubMed ID: 12486908
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Duodenal levodopa infusion monotherapy vs oral polypharmacy in advanced Parkinson disease.
    Nyholm D; Nilsson Remahl AI; Dizdar N; Constantinescu R; Holmberg B; Jansson R; Aquilonius SM; Askmark H
    Neurology; 2005 Jan; 64(2):216-23. PubMed ID: 15668416
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Treatment of advanced Parkinson's disease.
    Diamond A; Jankovic J
    Expert Rev Neurother; 2006 Aug; 6(8):1181-97. PubMed ID: 16893346
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Pramipexole, ropinirole, and mania in Parkinson's disease.
    Singh A; Althoff R; Martineau RJ; Jacobson J
    Am J Psychiatry; 2005 Apr; 162(4):814-5. PubMed ID: 15800169
    [No Abstract]   [Full Text] [Related]  

  • 38. Progression and prognosis in Parkinson's disease in relation to concomitant cerebral or peripheral vasculopathy.
    Scigliano G; Musicco M; Soliveri P; Girotti F; Giovannini P; Fetoni V; Caraceni T
    Adv Neurol; 1996; 69():305-9. PubMed ID: 8615143
    [No Abstract]   [Full Text] [Related]  

  • 39. Levodopa-induced modifications of prosody and comprehensibility in advanced Parkinson's disease as perceived by professional listeners.
    De Letter M; Santens P; Estercam I; Van Maele G; De Bodt M; Boon P; Van Borsel J
    Clin Linguist Phon; 2007 Oct; 21(10):783-91. PubMed ID: 17882694
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Medical management of advanced Parkinson's disease.
    Goudreau JL
    Clin Geriatr Med; 2006 Nov; 22(4):753-72, v. PubMed ID: 17000334
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.